DE112024001387T5 - Verfahren zum nachweis von krebs, verfahren zur vorhersage einer prognose von krebs, biomarker, verfahren zur verwendung eines biomarkers und kit zum nachweis von krebs oder zur vorhersage einer prognose von krebs - Google Patents

Verfahren zum nachweis von krebs, verfahren zur vorhersage einer prognose von krebs, biomarker, verfahren zur verwendung eines biomarkers und kit zum nachweis von krebs oder zur vorhersage einer prognose von krebs

Info

Publication number
DE112024001387T5
DE112024001387T5 DE112024001387.2T DE112024001387T DE112024001387T5 DE 112024001387 T5 DE112024001387 T5 DE 112024001387T5 DE 112024001387 T DE112024001387 T DE 112024001387T DE 112024001387 T5 DE112024001387 T5 DE 112024001387T5
Authority
DE
Germany
Prior art keywords
cancer
tetraspanin
detection
subject
biomarker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE112024001387.2T
Other languages
German (de)
English (en)
Inventor
gleich Anmelder Erfinder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE112024001387T5 publication Critical patent/DE112024001387T5/de
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE112024001387.2T 2023-03-24 2024-03-22 Verfahren zum nachweis von krebs, verfahren zur vorhersage einer prognose von krebs, biomarker, verfahren zur verwendung eines biomarkers und kit zum nachweis von krebs oder zur vorhersage einer prognose von krebs Pending DE112024001387T5 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2023-048820 2023-03-24
JP2023048820 2023-03-24
PCT/JP2024/011516 WO2024203968A1 (ja) 2023-03-24 2024-03-22 がんを検出する方法、がんの予後を予測する方法、バイオマーカー及びその使用方法、並びに、がんの検出用又はがんの予後の予測用キット

Publications (1)

Publication Number Publication Date
DE112024001387T5 true DE112024001387T5 (de) 2026-01-15

Family

ID=92905216

Family Applications (1)

Application Number Title Priority Date Filing Date
DE112024001387.2T Pending DE112024001387T5 (de) 2023-03-24 2024-03-22 Verfahren zum nachweis von krebs, verfahren zur vorhersage einer prognose von krebs, biomarker, verfahren zur verwendung eines biomarkers und kit zum nachweis von krebs oder zur vorhersage einer prognose von krebs

Country Status (3)

Country Link
JP (1) JPWO2024203968A1 (https=)
DE (1) DE112024001387T5 (https=)
WO (1) WO2024203968A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025197993A1 (ja) * 2024-03-22 2025-09-25 学校法人東邦大学 テトラスパニン１０陽性細胞外小胞の濃縮方法、及びがんを検出する又はがんの予後を予測する方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103782174A (zh) * 2011-06-07 2014-05-07 卡里斯生命科学卢森堡控股有限责任公司 用于癌症的循环生物标志物
EP3543701A4 (en) * 2016-10-28 2020-07-29 Japanese Foundation For Cancer Research BIOMARKER, METHOD OF SEARCHING FOR A GENE ASSOCIATED WITH A DISEASE, AND MARKER FOR KIDNEY CANCER
EP3716986A4 (en) * 2017-12-01 2022-02-09 Cornell University NANOPARTICLES AND VARIOUS EXOSOME SUBSETS FOR CANCER DETECTION AND TREATMENT
WO2020218121A1 (ja) * 2019-04-24 2020-10-29 公益財団法人がん研究会 癌を検出する方法および検出試薬
CN113939584A (zh) * 2019-12-02 2022-01-14 索尔生物公司 外泌体液体活检样本的制备装置和制备方法以及由此制备的外泌体液体活检样本的分析方法

Also Published As

Publication number Publication date
WO2024203968A1 (ja) 2024-10-03
JPWO2024203968A1 (https=) 2024-10-03

Similar Documents

Publication Publication Date Title
CN102105794B (zh) 移植物衰竭和死亡的标志物
Chan et al. Ultra-sensitive detection of protein biomarkers for diagnosis of Alzheimer’s disease
JP5337096B2 (ja) 動脈硬化の評価法
JP6192123B2 (ja) 乳癌の予測および診断のためのバイオマーカー
US9086412B2 (en) Extracellular vesicle-associated protein markers of cancer
WO2014124392A1 (en) Diagnostic tools to predict onset of preeclampsia
DE112024001387T5 (de) Verfahren zum nachweis von krebs, verfahren zur vorhersage einer prognose von krebs, biomarker, verfahren zur verwendung eines biomarkers und kit zum nachweis von krebs oder zur vorhersage einer prognose von krebs
JP5413818B2 (ja) 蛍光多重染色による蛋白定量法
EP1214447A2 (de) Nachweis des pyruvatkinase-isoenzyms im stuhl
US8133736B2 (en) Methods for detecting or monitoring cancer using LPE as a marker
JP6192122B2 (ja) 結腸直腸癌診断および予測のためのバイオマーカー
WO2023234422A1 (ja) 三次リンパ組織の検査方法、及び三次リンパ組織の検査用キット
US20140242608A1 (en) Composition for diagnosis of lung cancer and diagnosis kit for lung cancer
DE60012688T2 (de) Immunoassays zum nachweis von krankheiten oder krankheitsanfälligkeitsmerkmalen
EP2772759B1 (en) Composition for diagnosis of lung cancer
KR101334123B1 (ko) 소세포폐암 진단용 조성물 및 소세포폐암 진단키트
DE102016015060A1 (de) Verfahren zum Nachweis von Tumormarkern im Stuhl zur Erkennung gastrointestinaler Tumore
WO2025197993A1 (ja) テトラスパニン１０陽性細胞外小胞の濃縮方法、及びがんを検出する又はがんの予後を予測する方法
EP4617664A1 (en) A biomarker panel for early detection of cancer
CN117007819B (zh) 用于辅助诊断阿尔茨海默病的试剂盒
CN116754769B (zh) 一种用于预测转移性激素敏感性前列腺癌预后评估的蛋白组合物及其应用
DE102018000815A1 (de) Verfahren zum Nachweis von Biomarkern im Stuhl zur Erkennung von Erkrankungen des Intestinaltraktes
JP5167541B2 (ja) アポリポタンパク質ｃｉｉｉ０の血中濃度を指標とした胃癌の診断法
EP2937696B1 (en) Method for detecting prostatic basal cells
DE102009015784A1 (de) In-vitro-Verfahren zur Diagnostik von Tumorerkrankungen